The Consumentenbond warned on Thursday that insurers' practice of selecting only one cheap supplier per drug is exacerbating medicine shortages in the Netherlands and leaving patients to bear the cost ...

Irish dairy companies are expanding whey production as global demand rises alongside booming GLP-1 weight-loss drug use ...

Doctors say awareness about rare autoimmune disease among both public and frontline physicians remains low; high treatment costs add to burden.

Patients in Cyprus wait on average more than 500 days to access new medicines, one of the longest delays in Europe, as ...

Since his second term started, President Donald Trump has announced, negotiated, or floated a flurry of initiatives aimed at ...

Recently launched biosimilars across markets have begun scaling up and will gather momentum through the year, particularly in ...

The Medicines and Healthcare products Regulatory Agency (MHRA) is advising people taking GLP-1 medication such as Ozempic, ...

Source: Drug resistance risk as illicit medicine sales flourish in Harare – herald Ivan Zhakata CheckPoint Desk An ...

Pharma stocks have been attracting FIIs. Here are three stocks where FIIs have hiked stake in the March 2026 quarter.

Gilead’s HIV portfolio was a strong growth area for the company in Q1 2026. Credit: Tada Images / Shutterstock.com. Gilead Sciences has secured a good start to 2026 with its human immunodeficiency ...

Japan’s latest NHI drug price revision for FY26 has now come into effect, with an average 4.02% drop in prices on a spending basis across 15,800 products.